Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,973,454 papers from all fields of science
Search
Sign In
Create Free Account
Calcium Dobesilate
Known as:
Dobesilate, Calcium
, Benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1)
, Calcium Dobesilate [Chemical/Ingredient]
Expand
A drug used to reduce hemorrhage in diabetic retinopathy.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
14 relations
Broader (4)
2,5-Dihydroxybenzenesulfonate
2,5-Dihydroxybenzenesulfonic Acid
DOBESILIC ACID
Hemostatic Agents
Narrower (3)
Dexium Brand of Calcium Dobesilate
Doxium
doxivenil gel
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats.
Yi-Chen Dong
,
G. Wan
,
P. Yan
,
C. Qian
,
Fuzhen Li
,
Guanghua Peng
Journal of Photochemistry and Photobiology. B…
2019
Corpus ID: 153312767
Highly Cited
2010
Highly Cited
2010
Calcium Dobesilate Inhibits the Alterations in Tight Junction Proteins and Leukocyte Adhesion to Retinal Endothelial Cells Induced by Diabetes
E. Leal
,
J. Martins
,
+5 authors
A. Ambrósio
Diabetes
2010
Corpus ID: 11504773
OBJECTIVE Calcium dobesilate (CaD) has been used in the treatment of diabetic retinopathy in the last decades, but its mechanisms…
Expand
Highly Cited
2006
Highly Cited
2006
Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study
M. L. Ribeiro
,
A. Seres
,
+5 authors
on behalf of the OVIS-Study Group
Graefe's Archive for Clinical and Experimental…
2006
Corpus ID: 12655910
BackgroundThe study was carried out to confirm the effect of calcium dobesilate (CaD) compared to placebo (PLA) on the blood…
Expand
Review
2004
Review
2004
Safety of Calcium Dobesilate in Chronic Venous Disease, Diabetic Retinopathy and Haemorrhoids
H. Allain
,
A. Ramelet
,
E. Polard
,
D. Bentué‐Ferrer
Drug Safety
2004
Corpus ID: 45208706
The aim of the present review is to consider the adverse effects and the safety profile of calcium dobesilate. Calcium dobesilate…
Expand
Review
2004
Review
2004
Calcium Dobesilate for Chronic Venous Insufficiency: A Systematic Review
A. Ciapponi
,
E. Laffaire
,
M. Roqué
Angiology
2004
Corpus ID: 6089844
Chronic venous insufficiency (CVI) causes much discomfort and sick leave. Many randomized clinical trials (RCTs) have shown a…
Expand
Highly Cited
2003
Highly Cited
2003
Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF.
J. Angulo
,
P. Cuevas
,
+6 authors
I. Sáenz de Tejada
Biochemical and Biophysical Research…
2003
Corpus ID: 24994358
2001
2001
Efficacy of calcium dobesilate in treating acute attacks of hemorrhoidal disease
B. Menteş
,
A. Görgül
,
E. Tatlıcıoğlu
,
F. Ayoğlu
,
S. Ünal
Diseases of the Colon & Rectum
2001
Corpus ID: 40232839
PURPOSE: A randomized, double-blind, controlled study was conducted to investigate the efficacy of oral calcium dobesilate…
Expand
Highly Cited
1999
Highly Cited
1999
CALCIUM DOBESILATE: PHARMACOLOGICAL PROFILE RELATED TO ITS USE IN DIABETIC RETINOPATHY
P. Berthet
,
J. Farine
,
J. Barras
International journal of clinical practice
1999
Corpus ID: 31755333
Calcium dobesilate (Doxium®) is used in the treatment of diabetic retinopathy. Clinical studies show a slowdown of the…
Expand
Highly Cited
1998
Highly Cited
1998
In vitro antioxidant properties of calcium dobesilate
J. Brunet
,
J. Farine
,
R. Garay
,
P. Hannaert
Fundamental & Clinical Pharmacology
1998
Corpus ID: 23544192
Summary— Calcium dobesilate, a vascular protective agent, was tested in vitro for its scavenging action against oxygen free…
Expand
1988
1988
A Double-Blind Trial of Calcium Dobesilate in Chronic Venous Insufficiency
J. R. Casley-Smith
Angiology
1988
Corpus ID: 26413108
Calcium dobesilate was studied in a double-blind trial in 30 normal subjects and in 30 patients with chronic venous insufficiency…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE